Home › Funds › Siren, L.L.C. › SPTX

Siren, L.L.C. position in SPTX

Seaport Therapeutics Inc · Health Care

Siren, L.L.C. reported holding 1,095,316 shares of SPTX (Seaport Therapeutics Inc) in its Q3 2026 13F filing — a position valued at US$22.1M, representing 0.52% of its reported portfolio and ranking #45 among its reported holdings. Siren, L.L.C. has disclosed SPTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)1.10M sh
Reported value held$22.09M
Portfolio Weight0.52%
First reportedQ2 2026
Last changeHold
Updated2026-11-12

Last updated: 2026-11-12 · Source: SEC EDGAR Form 13F-HR

How Siren, L.L.C.'s SPTX position evolved

Siren, L.L.C. first disclosed a stake in SPTX in Q2 2026 at 1,095,316 shares (US$23.8M). Across 2 filings, Siren, L.L.C. held the position steady without any share-count change. The most recent filing (Q3 2026) shows 1,095,316 shares valued at US$22.1M.

Quarter by quarter

QuarterSharesValueChange
Q2 2026 1.10M $23.79M New
Q3 2026 1.10M $22.09M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About SPTX and 13F data

SPTX (Seaport Therapeutics Inc) is a Health Care company. 63 other funds we track also report a position in SPTX — the largest reported positions include ARCH Venture Management, LLC (US$136.6M), GENERAL ATLANTIC, L.P. (US$132.5M), Sofinnova Investments, Inc. (US$77.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding SPTX

All SPTX fund holders →

FAQ

How long has Siren, L.L.C. held SPTX?

Siren, L.L.C. has disclosed SPTX holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is Siren, L.L.C.'s current position in SPTX?

As of Q3 2026, Siren, L.L.C. holds 1.10M shares of SPTX (Seaport Therapeutics Inc), valued at $22.09M, representing 0.52% of its reported portfolio and ranking #45.

Has Siren, L.L.C. been buying or selling SPTX?

In the latest 13F filing (Q3 2026), Siren, L.L.C. held unchanged its position in SPTX.

Which other funds hold SPTX?

Other major institutional holders of SPTX include ARCH Venture Management, LLC, GENERAL ATLANTIC, L.P., Sofinnova Investments, Inc., among 63 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.